4-Methoxy-7-morpholinobenzo[d]thiazol-2-amine, 95.0%, 1g

(R)-2-((tert-Butoxycarbonyl)amino)-4-(3-chlorophenyl)butanoic acid, 95%, 250mg

Campesterol, ��98.0%, 5mg

Ethyl 2-(4-hydroxy-3-methoxyphenyl)acetate, 95.0%, 10g

(S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine, 95.0%, 1g

4-[(3-chloro-4-fluorophenyl)amino]-4-oxobutanoic acid, 95.0%, 1g

5-Bromo-3-(4-methoxyphenyl)-1-phenyl-1H-pyrazole-4-carbaldehyde, 95+%, 1g

5-Methoxypyrazolo[1,5-a]pyridine, 95%, 1g

3-Aminocyclobutanecarboxylic acid hydrochloride, 95.0%, 5g

(1-Methylethenyl)-benzene contains 15 ppm p-tert-butylcatechol as inhibitor, 95.0%, 100g

(3-(((tert-Butyldimethylsilyl)oxy)methyl)tetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol, 97%, 100mg

N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester, 97%, 100g

(S)-2-Allyl-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid, 95.0%, 250mg